Citi raised the firm’s price target on Incyte to $88 from $80 and keeps a Buy rating on the shares. The company reported a Q2 beat on better than expected growth for key franchises, including Jakafi and Opzelura, the analyst tells investors in a research note. The firm continues to view Incyte as well positioned as Jakafi and Opzelura drive commercial execution, and pipeline progress sets the stage for numerous readouts looking ahead.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INCY: